Cargando…
Higher incidence rates than previously known in tenosynovial giant cell tumors: A nationwide study in The Netherlands
Background and purpose — Tenosynovial giant cell tumors (TGCT) are rare, benign tumors, arising in synovial lining of joints, tendon sheaths, or bursae. 2 types are distinguished: localized, either digits or extremity, and diffuse lesions. Current TGCT incidence is based on 1 single US-county study...
Autores principales: | Mastboom, Monique J L, Verspoor, Floortje G M, Verschoor, Arjan J, Uittenbogaard, Daniël, Nemeth, Banne, Mastboom, Walter J B, Bovée, Judith V M G, Dijkstra, P D Sander, Schreuder, H W Bart, Gelderblom, Hans, Van de Sande, Michiel A J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694816/ https://www.ncbi.nlm.nih.gov/pubmed/28787222 http://dx.doi.org/10.1080/17453674.2017.1361126 |
Ejemplares similares
-
Limb Amputation after Multiple Treatments of Tenosynovial Giant Cell Tumour: Series of 4 Dutch Cases
por: Mastboom, Monique J. L., et al.
Publicado: (2017) -
Incidence and demographics of giant cell tumor of bone in The Netherlands: First nationwide Pathology Registry Study
por: Verschoor, Arie J, et al.
Publicado: (2018) -
Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
por: Mastboom, Monique J L, et al.
Publicado: (2018) -
The Patient Perspective on the Impact of Tenosynovial Giant Cell Tumors on Daily Living: Crowdsourcing Study on Physical Function and Quality of Life
por: Mastboom, Monique Josephine, et al.
Publicado: (2018) -
Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor
por: Verspoor, F. G. M., et al.
Publicado: (2019)